C Richard Boland

Title: C Richard Boland: Innovator in Colorectal Cancer Research

Introduction

C Richard Boland is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of colorectal cancer research. With a total of six patents to his name, Boland has developed innovative methods and biomarkers that enhance the diagnosis and treatment of colorectal cancer.

Latest Patents

One of Boland's latest patents focuses on the identification of metastasis-specific miRNA and hypomethylation signatures in human colorectal cancer. This invention includes methods for diagnosing or detecting colorectal cancer metastasis by comparing the Alu repeat methylation level in biological samples. A decrease in this methylation level indicates the presence of colorectal cancer and its metastasis. Additionally, the invention provides methods for assessing the expression levels of specific miRNAs, such as let-7i, miR-10b, miR-320a, and miR-221, which can indicate prognosis for colorectal cancer patients. Another significant patent involves the analysis of miR-320e, which aids in determining treatment strategies for colorectal cancer patients based on the expression levels of certain miRNAs.

Career Highlights

C Richard Boland is affiliated with the Baylor Research Institute, where he continues to advance research in colorectal cancer. His work has been instrumental in developing diagnostic tools that improve patient outcomes and treatment strategies.

Collaborations

Boland has collaborated with notable researchers in the field, including Ajay Goel and Yuji Toiyama. These partnerships have contributed to the advancement of knowledge and innovation in cancer research.

Conclusion

C Richard Boland's innovative work in colorectal cancer research has led to the development of critical diagnostic methods and treatment strategies. His contributions continue to impact the field significantly, improving the lives of patients diagnosed with colorectal cancer.